1. Home
  2. GLSI vs YMT Comparison

GLSI vs YMT Comparison

Compare GLSI & YMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLSI
  • YMT
  • Stock Information
  • Founded
  • GLSI 2006
  • YMT 2011
  • Country
  • GLSI United States
  • YMT China
  • Employees
  • GLSI N/A
  • YMT N/A
  • Industry
  • GLSI Biotechnology: Pharmaceutical Preparations
  • YMT EDP Services
  • Sector
  • GLSI Health Care
  • YMT Technology
  • Exchange
  • GLSI Nasdaq
  • YMT Nasdaq
  • Market Cap
  • GLSI 145.2M
  • YMT 172.7M
  • IPO Year
  • GLSI 2020
  • YMT 2025
  • Fundamental
  • Price
  • GLSI $8.66
  • YMT $1.37
  • Analyst Decision
  • GLSI Strong Buy
  • YMT
  • Analyst Count
  • GLSI 1
  • YMT 0
  • Target Price
  • GLSI $39.00
  • YMT N/A
  • AVG Volume (30 Days)
  • GLSI 81.6K
  • YMT 26.6K
  • Earning Date
  • GLSI 11-14-2025
  • YMT 01-01-0001
  • Dividend Yield
  • GLSI N/A
  • YMT N/A
  • EPS Growth
  • GLSI N/A
  • YMT N/A
  • EPS
  • GLSI N/A
  • YMT N/A
  • Revenue
  • GLSI N/A
  • YMT $21,547,440.00
  • Revenue This Year
  • GLSI N/A
  • YMT N/A
  • Revenue Next Year
  • GLSI N/A
  • YMT N/A
  • P/E Ratio
  • GLSI N/A
  • YMT N/A
  • Revenue Growth
  • GLSI N/A
  • YMT 19.68
  • 52 Week Low
  • GLSI $7.88
  • YMT $1.35
  • 52 Week High
  • GLSI $15.47
  • YMT $6.05
  • Technical
  • Relative Strength Index (RSI)
  • GLSI 38.48
  • YMT N/A
  • Support Level
  • GLSI $8.02
  • YMT N/A
  • Resistance Level
  • GLSI $9.51
  • YMT N/A
  • Average True Range (ATR)
  • GLSI 0.57
  • YMT 0.00
  • MACD
  • GLSI -0.06
  • YMT 0.00
  • Stochastic Oscillator
  • GLSI 31.88
  • YMT 0.00

About GLSI Greenwich LifeSciences Inc.

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.

About YMT Yimutian Inc. American Depositary Shares

Yimutian Inc is the largest agricultural B2B platform in mainland China. It provide a comprehensive set of digital solutions to facilitate agricultural product transactions, ranging from searching, matching, to transaction facilitation and settlement. The company pride itself as the go-to platform for merchants by leveraging its inventive technology and industry know-how. Its platform had over 38 million merchants. It has also established approximately 12 offline stores in mainland China to trade agricultural products at cultivation and production sites with sellers and buyers.

Share on Social Networks: